Excelsior Medical Co., Ltd. (TPE:4104)
Taiwan · Delayed Price · Currency is TWD 77.90
+0.40 (0.52%)
Apr 2, 2026, 1:30 PM CST
Excelsior Medical Market Cap
Excelsior Medical has a market cap or net worth of 13.37 billion as of April 2, 2026. Its market cap has decreased by -6.52% in one year.
Market Cap
13.37B
Enterprise Value
14.52B
Revenue
8.79B
Ranking
n/a
PE Ratio
16.65
Stock Price
77.90
Market Cap Chart
Since July 3, 2003, Excelsior Medical's market cap has increased from 2.50B to 13.37B, an increase of 434.84%. That is a compound annual growth rate of 7.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 13.37B | -4.53% |
| Dec 31, 2025 | 14.00B | -0.37% |
| Dec 31, 2024 | 14.05B | 2.15% |
| Dec 29, 2023 | 13.76B | 37.31% |
| Dec 30, 2022 | 10.02B | 23.23% |
| Dec 30, 2021 | 8.13B | 2.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 222.70B |
| Caliway Biopharmaceuticals | 134.02B |
| Bora Pharmaceuticals | 58.29B |
| Heron Neutron Medical | 54.81B |
| YungShin Global Holding | 14.52B |
| TaiMed Biologics | 14.02B |
| Visco Vision | 12.44B |
| Ever Supreme Bio Technology | 12.44B |